Compare BBNX & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBNX | TRIN |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2025 | 2021 |
| Metric | BBNX | TRIN |
|---|---|---|
| Price | $29.39 | $14.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $28.09 | $15.63 |
| AVG Volume (30 Days) | 618.5K | ★ 766.1K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 13.67% |
| EPS Growth | N/A | ★ 25.79 |
| EPS | N/A | ★ 2.17 |
| Revenue | $88,570,000.00 | ★ $268,271,000.00 |
| Revenue This Year | $52.13 | $29.07 |
| Revenue Next Year | $36.16 | $13.52 |
| P/E Ratio | ★ N/A | $6.89 |
| Revenue Growth | ★ 67.01 | 30.76 |
| 52 Week Low | $8.89 | $12.50 |
| 52 Week High | $32.71 | $16.82 |
| Indicator | BBNX | TRIN |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 54.74 |
| Support Level | $27.87 | $14.47 |
| Resistance Level | $31.51 | $14.92 |
| Average True Range (ATR) | 2.09 | 0.23 |
| MACD | -0.22 | 0.05 |
| Stochastic Oscillator | 47.23 | 94.41 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.